Stock Comparison

ARGX vs RVMD

argenx NV ADR and Revolution Medicines Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

RVMD

Revolution Medicines Inc

Healthcare

Valuation

Market Cap

$53.23B

$42.92B

P/E (TTM)

32.7

—

Forward P/E

30.4

—

Price/Sales

10.0

8,818.1

Price/Book

6.4

16.5

EV/EBITDA

27.6

-9.5

Dividend Yield

—

Profitability

Net Margin

30.44%

0.00%

Operating Margin

27.34%

0.00%

Return on Equity

23.60%

-76.70%

Return on Assets

11.60%

-37.50%

Growth (YoY)

Revenue Growth

59.30%

-95.20%

Earnings Growth

95.20%

0.00%

Price & Risk

Beta

-0.0

1.4

52-Week High

$939.68

$206.97

52-Week Low

$652.43

$35.67

Analyst Target

$1,085.78

$213.66

Compare ARGX and RVMD your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.